Abstract
An isocratic reverse phase liquid chromatographic (RP-LC) assay method has been developed for the quantitative determination of nateglinide and its related components namely imp-1 and imp-2 in bulk drug and in pharmaceutical dosage form, used for the treatment of type II diabetes mellitus. The developed method is stability indicating and also can be used for stability testing. The chromatographic separation was achieved on C-8, 150 × 4.6 mm, 3.5 μm stationary phase. The LC method employs solution A as mobile phase. Solution A contains a mixture of phosphate buffer pH 3.0: acetonitrile (50:50 v/v). The flow rate was 1.0 mL min−1 and the detection wavelength was 210 nm. In the developed LC method the resolution between nateglinide and its potential impurities namely imp-1 and imp-2 was found to be greater than 5.0. The drug was subjected to stress conditions of hydrolysis, oxidation, photolysis and thermal degradation. Considerable degradation was found to occur in acid medium, alkaline medium and oxidative stress conditions. The stress samples were assayed against a qualified reference standard and the mass balance was found close to 99.2%. The developed RP-LC method was validated with respect to linearity, accuracy, precision and robustness.
Similar content being viewed by others
References
Fujitani S, Okazaki K, Yada T (1997) Br J Pharmacol 120:1191–1198
Karara AH, Dunning BE, McLeod JF (1999) J Clin Pharmacol 39:172–179
Dunn CJ, Faulds D (2000) Drugs 60:607–615
Fujitani S, Yada T (1994) Endocrinology 134:1395–1400
Yoshikazu N, Hiroyui A, Makoto I, Kazutoshi T, Kazuo H, Shoj T (1999) Yakuri to Chiryo 27:1177–1203
Keilson L, Mather S, Walter YH, Subramanian S, Mcleod JF (2000) J Clin Endocrinol .Metab 85:1081–1086
Sankalia JM, Sankalia MG, Sutariya VB, Mashru RC (2007) J Pharm Biomed Anal 44:196–204
Hongyuan Yan, Gengliang Yang, Fengxia Qiao, Yi Chen (2004) J Pharm Biomed Anal 36:169–174
Bauer S, Störmer E, Kirchheiner J, Michael C, Brockmöller J, Roots I (2003) J Pharm Biomed Anal 31:551–555
Ono I, Matsuda K, Kanno S (1997) J Chromatogr B 692:397–404
Ono I, Matsuda K, Kanno S (1996) J Chromatogr B Biomed Sci Appl 678:384–387
Malli D, Gikas E, Vavagiannis A, Kazanis M, Daniilides K, Gennimata D, Panderi I (2007) Anal Chim Acta 599:143–150
ICH Stability Testing of New Drug Substances and Products Q1A (R2) (2003) International Conference on Harmonization, IFPMA, Geneva
Singh S, Bakshi M (2000) Pharm Tech On-line 24:1–14
ICH, Photo Stability Testing of New Drug Substances and Products Q1B (1996) International Conference on Harmonization, IFPMA, Geneva
Bakshi M, Singh S, Pharm J (2002) Biomed Anal 28:1011–1040
Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R (2006) J Pharm Biomed Anal 41:1037–1040
Carstensen JT, Rhodes CT (eds) (2000) Drug stability principles and practices, 3rd edn
ICH Guidelines on Validation of Analytical Procedures: Text and Methodology Q2 (R1) (1995): FDA: Published in the Federal Register, vol 60, p 11260, March 1, 1995
Acknowledgments
The authors wish to thank the management of Dr. Reddys Laboratories Ltd for supporting this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Madhavi, A., Reddy, G.S., Suryanarayana, M.V. et al. Development of a New Analytical Method for Determination of Related Components in Nateglinide. Chroma 67, 639–645 (2008). https://doi.org/10.1365/s10337-008-0548-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0548-z